ADMA Biologics ADMA Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
Based on trailing twelve months.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's free cash flow margin?
- ADMA Biologics (ADMA) reported free cash flow margin of 21.2% in Q1 2026.
- How has ADMA Biologics's free cash flow margin changed year-over-year?
- ADMA Biologics's free cash flow margin increased by 7.3% year-over-year, from 19.7% to 21.2%.
- What is the long-term trend for ADMA Biologics's free cash flow margin?
- Over 5 years (2020 to 2025), ADMA Biologics's free cash flow margin has grown at a -54.2% compound annual growth rate (CAGR), from -271.7% to 5.5%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.